Laura Ramirez-Feldman

  • FDA advisory panel authorizes Pfizer's vaccine for children 5-11

    A key federal advisory committee voted Tuesday to recommend emergency authorization of the Pfizer mRNA COVID-19 vaccines for children between the ages of 5 and 11, a sign that the shot will likely be authorized for this age group in the next week.

  • You have COVID booster shot questions. We have answers.

    Yahoo News spoke recently to Dr. Lucy McBride, who specializes in internal medicine, to break down what Americans need to know about boosters and the new mix and match approach.

  • Where does natural immunity stand in fight over vaccine mandates?

    One argument against the COVID-19 vaccine mandates is that immunity from a previous coronavirus infection should count as an alternative to vaccination. What does the scientific evidence say about which offers better protection — natural immunity or vaccine immunity?

  • Everything you need to know about booster shots for COVID-19

    Yahoo News spoke to its medical contributor, Dr. Kavita Patel, to cut through the confusion about the latest FDA and CDC guidance on COVID-19 vaccine booster shots.

  • CDC advisory committee recommends Pfizer's booster shot for certain adults

    The CDC’s Advisory Committee on Immunization Practices on Thursday voted to endorse COVID-19 booster shots for a wide range of individuals, including adults 65 and older, long-term care facility residents and people 50-64 with underlying health conditions.

  • Here's what's next for COVID vaccine booster shots

    A key U.S. advisory panel has green-lit booster shots of COVID-19 vaccines for older adults and people at high risk of disease, but regulators say they don’t yet have enough evidence for the broader population.

  • Are Biden's vaccine requirements legal?

    On Tuesday, Arizona became the first state to sue the Biden administration over new COVID-19 vaccine requirements announced by the president on Sept. 9.

  • Vaccines still work: CDC studies show COVID breakthrough infection rate remains low despite Delta variant

    Breakthrough cases of COVID-19 among vaccinated people remain rare (and are generally less serious when they do occur), despite the surge of the hypercontagious Delta variant.

  • Is the outdoors still safe? Concerns about Delta prompt new guidelines

    As the hypercontagious Delta variant continues to drive up cases of COVID-19 in parts of the country, many have begun to wonder if this strain is also more transmissible outdoors, particularly as Labor Day approaches and many Americans are planning outdoor gatherings.

  • COVID-19 vaccine booster shots: What you need to know

    This week the Biden administration announced it was recommending booster shots of the Moderna and Pfizer vaccines for many Americans as early as Sept. 20.

  • How the FDA's full approval could affect COVID-19 vaccinations

    The rise of the Delta variant has put mounting pressure on the Food and Drug Administration to fully approve the COVID-19 vaccines under emergency use authorization.

  • 'Don't let us be your nurse': Health care worker describes Florida surge

    Florida has shattered its records for COVID-19 hospitalizations, with admissions increasing tenfold in just over a month and hospitals' COVID-19 wards filling after nearly emptying in June. The state now also leads the nation in per capita hospitalizations for COVID-19.

  • Delta variant: 7 things to know about the highly contagious coronavirus strain

    After declining sharply for months, coronavirus cases in the U.S are climbing again as a result of the Delta variant. Here's what to know about the fast-spreading variant and how to stay safe and protect others.

  • Spike in hospitalizations due to Delta variant underscores need for COVID-19 vaccination, experts say

    Due to uneven vaccination rates and new strains of the coronavirus, the pandemic has come in waves that have crashed in different parts of the U.S. at different times. Health experts say the recent uptick in cases is primarily due to localized outbreaks in areas with low vaccination rates.

  • Experts push FDA to fully authorize Pfizer and Moderna COVID-19 vaccines

    Now that the Delta coronavirus variant is posing a serious risk to unvaccinated Americans, some experts are calling for the Food and Drug Administration to fully approve the Pfizer and Moderna COVID-19 vaccines, which are currently being used under emergency use authorization. Granting full approval, these experts argue, is a key step to address vaccine hesitancy, and to help persuade Americans to get the shots. Vaccine holdouts are potentially at great risk of contracting the Delta variant, which is quickly becoming dominant in the United States.

  • Expert shares how we can protect children from coronavirus Delta variant

    The Delta variant, which accounts for about 20 percent of COVID-19 cases in the U.S., is expected to become the dominant strain of the virus in coming months — if not sooner, experts say.

  • The COVID-19 Delta variant: What you need to know

    This week, the Centers for Disease Control and Prevention officially declared the Delta variant, a coronavirus strain first detected in India, “a variant of concern.” This designation is given to variants shown to be more transmissible than the original strain, that can cause more severe disease and potentially reduce the effectiveness of treatments or vaccines. Yahoo News Medical Contributor Dr. Kavita Patel, a primary care physician in Washington, D.C., who also serves as a health policy fellow at the Brookings Institution, answered some questions about the Delta variant, which some experts have called “the most troubling variant by far.”

  • What we know about COVID vaccine booster shots — and when we may need them

    Now that almost half the U.S. population is fully vaccinated against COVID-19, many people are beginning to wonder how long that protection will last, and if they will need a booster shot down the road.

  • New CDC guidance for vaccinated people brings confusion along with relief

    Thursday’s announcement by the CDC that people who are fully vaccinated against the coronavirus do not have to wear masks in most indoor or outdoor situations was a landmark moment in the fight against COVID-19. But relief was accompanied by confusion.

  • Doctor explains why parents shouldn't wait to vaccinate their kids

    Now that Pfizer’s COVID-19 vaccine has been approved for use in kids as young as 12, Yahoo News Medical Contributor Dr. Kavita Patel says parents should consider vaccinating their children “as soon as possible.”